Your browser doesn't support javascript.
loading
EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
Chen, Kenneth S; Fustino, Nicholas J; Shukla, Abhay A; Stroup, Emily K; Budhipramono, Albert; Ateek, Christina; Stuart, Sarai H; Yamaguchi, Kiyoshi; Kapur, Payal; Frazier, A Lindsay; Lum, Lawrence; Looijenga, Leendert H J; Laetsch, Theodore W; Rakheja, Dinesh; Amatruda, James F.
Affiliation
  • Chen KS; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Fustino NJ; Margaret Gill Center for Cancer and Blood Disorders, Children's Health Medical Center, Dallas, Texas.
  • Shukla AA; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Stroup EK; Margaret Gill Center for Cancer and Blood Disorders, Children's Health Medical Center, Dallas, Texas.
  • Budhipramono A; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Ateek C; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Stuart SH; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Yamaguchi K; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Kapur P; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Frazier AL; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Lum L; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Looijenga LHJ; Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Laetsch TW; Division of Clinical Genome Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Rakheja D; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Amatruda JF; Department of Pediatric Oncology, Children's Hospital Dana-Farber Cancer Care, Boston, Massachusetts.
Mol Cancer Ther ; 17(5): 1079-1089, 2018 05.
Article in En | MEDLINE | ID: mdl-29483210

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal / Xenograft Model Antitumor Assays / ErbB Receptors / Mechanistic Target of Rapamycin Complex 1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal / Xenograft Model Antitumor Assays / ErbB Receptors / Mechanistic Target of Rapamycin Complex 1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article